DNA copy number variations at chromosome 7p14.1 and chromosome 14q11.2 are associated with Dupuytren's disease: Potential role for MMP and Wnt signaling pathway

Plastic and Reconstructive Surgery

Volumn 129, Issue 4, 2012, Pages 921-932

  Shih, Barbara ^a,b   Tassabehji, May ^a,b   Watson, James Stewart ^a,b   Bayat, Ardeshir ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE 14;

AGED; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 14; CHROMOSOME 7; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DUPUYTREN CONTRACTURE; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WNT SIGNALING PATHWAY;

AGED; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 7; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; DUPUYTREN CONTRACTURE; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 14; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; WNT SIGNALING PATHWAY;

EID: 84859434488     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182442343     Document Type: Article

References (44)

1. Shih B, Bayat A. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol. 2010;6: 715-726.
2. Burge P. Genetics of Dupuytren's disease. Hand Clin. 1999; 15:63-71.
3. Bayat A, McGrouther DA. Management of Dupuytren's disease: Clear advice for an elusive condition. Ann R Coll Surg Engl. 2006;88:3-8.
4. Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology. Hand (N Y). 2009;4:256-269.
5. Hindocha S, John S, Stanley JK, Watson SJ, Bayat A. The heritability of Dupuytren's disease: Familial aggregation and its clinical significance. J Hand Surg Am. 2006;31:204-210.
6. Hindocha S, Stanley JK, Watson S, Bayat A. Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg Am. 2006;31:1626-1634.
7. Ling RS. The genetic factor in Dupuytren's disease. J Bone Joint Surg Br. 1963;45:709-718.
8. Bayat A, Alansar A, Hajeer AH, et al. Genetic susceptibility in Dupuytren's disease: Lack of association of a novel transforming growth factor beta(2) polymorphism in Dupuytren's disease. J Hand Surg Br. 2002;27:47-49.
9. Dolmans GH, Werker PM, Hennies HC, et al. Wnt signaling and Dupuytren's disease. N Engl J Med. 2011;365:307-317.
10. Bayat A, Stanley JK, Watson JS, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren's disease: Transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease. Br J Plast Surg. 2003;56: 328-333.
11. Bayat A, Watson JS, Stanley JK, et al. Genetic susceptibility in Dupuytren's disease: TGF-beta1 polymorphisms and Dupuytren's disease. J Bone Joint Surg Br. 2002;84:211-215.
12. Bayat A, Watson JS, Stanley JK, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren disease: Association of Zf9 transcription factor gene. Plast Reconstr Surg. 2003;111: 2133-2139.
13. Brown JJ, Ollier W, Thomson W, Bayat A. Positive association of HLA-DRB1*15 with Dupuytren's disease in Caucasians. Tissue Antigens 2008;72:166-170.
14. Bayat A, Walter J, Lambe H, et al. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg. 2005;115:134-141.
15. Hu FZ, Nystrom A, Ahmed A, et al. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet. 2005;68:424-429.
16. Ojwang JO, Adrianto I, Gray-McGuire C, et al. Genome-wide association scan of Dupuytren's disease. J Hand Surg Am. 2010;35:2039-2045.
17. Kaur S, Forsman M, Ryhanen J, Knuutila S, Larramendy ML. No gene copy number changes in Dupuytren's contracture by array comparative genomic hybridization. Cancer Genet Cytogenet. 2008;183:6-8.
18. Shih BB, Tassabehji M, Watson JS, McGrouther AD, Bayat A. Genome-wide high-resolution screening in Dupuytren's disease reveals common regions of DNA copy number alterations. J Hand Surg Am. 2010;35:1172-1183.
19. Speleman F, Kumps C, Buysse K, Poppe B, Menten B, De Preter K. Copy number alterations and copy number variation in cancer: Close encounters of the bad kind. Cytogenet Genome Res. 2008;123:176-182.
20. McCarroll SA. Copy-number analysis goes more than skin deep. Nat Genet. 2008;40:5-6.
21. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/ AIDS susceptibility. Science 2005;307:1434-1440.
22. Braude I, Vukovic B, Prasad M, et al. Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia. BMC Genomics 2006;7:138.
23. Bonnici AV, Birjandi F, Spencer JD, Fox SP, Berry AC. Chromosomal abnormalities in Dupuytren's contracture and carpal tunnel syndrome. J Hand Surg Br. 1992;17:349-355.
24. Bowser-Riley S, Bain AD, Noble J, Lamb DW. Chromosome abnormalities in Dupuytren's disease. Lancet 1975;2:1282-1283.
25. Casalone R, Mazzola D, Meroni E, et al. Cytogenetic and interphase cytogenetic analyses reveal chromosome instability but no clonal trisomy 8 in Dupuytren contracture. Cancer Genet Cytogenet. 1997;99:73-76.
26. Sergovich FR, Botz JS, McFarlane RM. Nonrandom cytogenetic abnormalities in Dupuytren's disease. N Engl J Med. 1983;308:162-163.
27. Wurster-Hill DH, Brown F, Park JP, Gibson SH. Cytogenetic studies in Dupuytren contracture. Am J Hum Genet. 1988;43: 285-292.
28. Chen Y, Chen C. DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: A review. Head Neck 2008;30:1361-1383.
29. Shih B, Wijeratne D, Armstrong DJ, Lindau T, Day P, Bayat A. Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in diseasespecific phenotypes. J Hand Surg Am. 2009;34:124-136.
30. Karolchik D, Hinrichs AS, Furey TS, et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 2004;32:D493-D496.
31. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res. 2002;12:996-1006.
32. Henrichsen CN, Vinckenbosch N, Zollner S, et al. Segmental copy number variation shapes tissue transcriptomes. Nat Genet. 2009;41:424-429.
33. Zogopoulos G, Ha KC, Naqib F, et al. Germ-line DNA copy number variation frequencies in a large North American population. Hum Genet. 2007;122:345-353.
34. de Smith AJ, Tsalenko A, Sampas N, et al. Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: Implications for association studies of complex diseases. Hum Mol Genet. 2007;16:2783-2794.
35. Perry GH, Ben-Dor A, Tsalenko A, et al. The fine-scale and complex architecture of human copy-number variation. Am J Hum Genet. 2008;82:685-695.
36. Walsh KM, Bracken MB, Murk WK, Hoh J, Dewan AT. Association between reduced copy-number at T-cell receptor gamma (TCRgamma) and childhood allergic asthma: A possible role for somatic mosaicism. Mutat Res. 2010;690:89-94.
37. Clifford RJ, Zhang J, Meerzaman DM, et al. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology 2010;52: 2034-2043.
38. Schwienbacher C, De Grandi A, Fuchsberger C, et al. Copy number variation and association over T-cell receptor genes: Influence of DNA source. Immunogenetics 2010;62:561-567.
39. Baird KS, Alwan WH, Crossan JF, Wojciak B. T-cell-mediated response in Dupuytren's disease. Lancet 1993;341:1622-1623.
40. Gudmundsson KG, Arngrimsson R, Arinbjarnarson S, Olafsson A, Jonsson T. T-and B-lymphocyte subsets in patients with Dupuytren's disease: Correlations with disease severity. J Hand Surg Br. 1998;23:724-727.
41. Mosakhani N, Guled M, Lahti L, et al. Unique microRNA profile in Dupuytren's contracture supports deregulation of beta-catenin pathway. Mod Pathol. 2010;23:1544-1552.
42. Johnston P, Chojnowski AJ, Davidson RK, Riley GP, Donell ST, Clark IM. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease. J Hand Surg Am. 2007;32:343-351.
43. Qian A, Meals RA, Rajfer J, Gonzalez-Cadavid NF. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology 2004;64:399-404.
44. Johnston P, Larson D, Clark IM, Chojnowski AJ. Metalloproteinase gene expression correlates with clinical outcome in Dupuytren's disease. J Hand Surg Am. 2008;33:1160-1167.